Dr. Platin has been named the Chief Dental Imaging Officer of XinVivo.
Mr. David LaVance has been named the new President and CEO of XinVivo.
A new study conducted at the University of North Carolina School of Dentistry showed that “stationary digital intraoral tomosynthesis substantially reduces proximal surface overlap compared to conventional bitewing radiography”.
XinVivo’s 3D intraoral device TomoD is now being evaluated in an IRB approved patient study at the University of North Carolina School of Dentistry dental clinic.
The U.S. Patent and Trade Office today granted UNC/Xintek another broad patent on our stationary intraoral tomosynthesis technology. The patent (US 9,907,520 B2) is exclusively licensed by XinVivo.
Our stationary intraoral tomosynthesis imaging patent is issued today by the U.S. Patent and Trade Office.
WRAL (CBS NC Station) featured our 3D intraoral tomosynthesis technology.
Researchers at the University of North Carolina are working with Xintek Inc. to develop a clinically viable 3-D intraoral imaging system, with the potential of changing the way dental radiographs are taken in the future.